Apria Healthcare Group Inc., a provider of home healthcare products and services, said Thursday the proposed sale of the company to an affiliate of Blackstone Group LP cleared an antitrust regulatory review.
In June, Apria said Blackstone would acquire the health care company for $21 per share in cash, or about $921.9 million. Shares of Apria closed Wednesday at $18.94.
The sale of Apria is still subject to other conditions, including shareholder approval.
The deal is expected to close by the end of the year.